Seattle Genetics/ US81181C1045 /
2023-12-13 10:19:51 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
228.86USD | - | 577,731 Turnover: 132.25 mill. |
-Bid Size: - | -Ask Size: - | 43.15 bill.USD | - | - |
Fundamentals
FY 2022 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -3.30 USD | -10.81% |
EPS Diluted: | -3.30 USD | -10.81% |
Revenues per Share: | 10.51 USD | 22.54% |
Book Value per Share: | 15.01 USD | -10.07% |
Cash Flow per Share: | -2.43 USD | -10.61% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 1,962.41 USD | 24.65% |
Net Income: | -610.31 USD | -9.51% |
Operating Cash Flow: | -453.75 USD | - |
Cash and Cash Equivalents: | 319.94 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 21.77 | 12.23 |
P/BV ratio: | 15.24 | 8.56 |
P/CF Ratio: | -94.16 | -52.90 |
PEG: | 6.41 | - |
Earnings Yield: | -1.44% | -2.57% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 43.15 bill. USD | 24 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | 13.12 mill. USD | 7.37 mill. USD |
Shares Outstanding: | 188.66 mill. |
Profitability
Gross Profit Margin: | 79.10% |
EBIT Margin: | -31.24% |
Net Profit Margin: | -31.10% |
Return on Equity: | -21.77% |
Return on Assets: | -16.61% |
Financial Strength
Liquidity I / Cash Ratio: | 39.09% |
Liquidity II / Quick Ratio: | 100.42% |
Liquidity III / Current Ratio: | 342.44% |
Debt / Equity Ratio: | 31.05% |
Dynam. Debt / Equity Ratio: | -191.89% |
Efficiency
Employees: | 3,256 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 602,706.39 USD |
Net Income / Employee: | -187,441.03 USD |
Total Assets / Employee: | 1,128,541.77 USD |
* Fiscal Year End: | 2022-12-31 |
Accounting Standard: | US GAAP |
Currency: | USD |